Dr. Brasier joined UW ICTR in 2018. He received his MD degree from the University of California, San Francisco, a clinical and research fellowship in adult endocrinology at Massachusetts General Hospital and is dually boarded in internal medicine and endocrinology/metabolism. He was the founding director of the Institute for Translational Science at the University of Texas Medical Branch, where he developed systematic approaches for advancing translational research. This work in translational teams is now being applied and advanced at ICTR and has led to the development of approaches to enhance reproducibility in science and skills-based training in research leadership.
In addition to his contributions to translational teamwork, Dr. Brasier is internationally recognized for his original and high-impact research on the mechanisms of innate inflammation and its role in advancing pulmonary and cardiovascular disease. His pioneering work applies systems-level bioinformatics to integrate information from high-throughput studies to generate novel mechanistic insights about innate inflammation and its central role in organ fibrosis. These studies inform translational research programs in viral induced inflammation, airway remodeling and idiopathic pulmonary fibrosis.
Research Keywords & Expertise
next generation sequen...
Innate immunity, unfol...
Paramyxoviridae
Rhinoviridae
High resolution proteo...
Short Biography
Dr. Brasier joined UW ICTR in 2018. He received his MD degree from the University of California, San Francisco, a clinical and research fellowship in adult endocrinology at Massachusetts General Hospital and is dually boarded in internal medicine and endocrinology/metabolism. He was the founding director of the Institute for Translational Science at the University of Texas Medical Branch, where he developed systematic approaches for advancing translational research. This work in translational teams is now being applied and advanced at ICTR and has led to the development of approaches to enhance reproducibility in science and skills-based training in research leadership.
In addition to his contributions to translational teamwork, Dr. Brasier is internationally recognized for his original and high-impact research on the mechanisms of innate inflammation and its role in advancing pulmonary and cardiovascular disease. His pioneering work applies systems-level bioinformatics to integrate information from high-throughput studies to generate novel mechanistic insights about innate inflammation and its central role in organ fibrosis. These studies inform translational research programs in viral induced inflammation, airway remodeling and idiopathic pulmonary fibrosis.
